Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lintzeris

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
Accident; Analysis and Prevention|October 5, 2020
Driving-Related Behaviours, Attitudes and Perceptions among Australian Medical Cannabis Users: Results from the CAMS 18-19 SurveyThomas R Arkell, Nicholas Lintzeris, Llewellyn Mills, et al.
Harm Reduction Journal|July 30, 2022
Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)Nicholas Lintzeris, Llewellyn Mills, Sarah V Abelev, et al.
The International Journal on Drug Policy|May 11, 2022
Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer painRia E Hopkins, Gabrielle Campbell, Louisa Degenhardt, et al.
The Lancet. Psychiatry|September 12, 2015
Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort studyLouisa Degenhardt, Raimondo Bruno, Nicholas Lintzeris, et al.
Drug and Alcohol Review|October 15, 2013
Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinicsTeodora Groshkova, Nicola Metrebian, Christopher Hallam, et al.
Substance Abuse Treatment, Prevention, and Policy|October 8, 2022
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorderLlewellyn Mills, Adrian Dunlop, Mark Montebello, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 14, 2013
Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addictionSarah Byford, Barbara Barrett, Nicola Metrebian, et al.
Drug and Alcohol Review|November 21, 2013
Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sampleJessica Belcher, Suzanne Nielsen, Gabrielle Campbell, et al.
Drug and Alcohol Review|July 31, 2015
Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, AustraliaSuzanne Nielsen, Raimondo Bruno, Bridin Murnion, et al.
Drug and Alcohol Review|February 4, 2025
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open-label, non-randomised trial of long-acting injectable buprenorphine treatment in Australian custodial settingsBethany White, Sophia Little, Paul S Haber, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
Accident; Analysis and Prevention|October 5, 2020
Driving-Related Behaviours, Attitudes and Perceptions among Australian Medical Cannabis Users: Results from the CAMS 18-19 SurveyThomas R Arkell, Nicholas Lintzeris, Llewellyn Mills, et al.
Harm Reduction Journal|July 30, 2022
Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)Nicholas Lintzeris, Llewellyn Mills, Sarah V Abelev, et al.
The International Journal on Drug Policy|May 11, 2022
Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer painRia E Hopkins, Gabrielle Campbell, Louisa Degenhardt, et al.
The Lancet. Psychiatry|September 12, 2015
Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort studyLouisa Degenhardt, Raimondo Bruno, Nicholas Lintzeris, et al.
Drug and Alcohol Review|October 15, 2013
Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinicsTeodora Groshkova, Nicola Metrebian, Christopher Hallam, et al.
Substance Abuse Treatment, Prevention, and Policy|October 8, 2022
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorderLlewellyn Mills, Adrian Dunlop, Mark Montebello, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 14, 2013
Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addictionSarah Byford, Barbara Barrett, Nicola Metrebian, et al.
Drug and Alcohol Review|November 21, 2013
Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sampleJessica Belcher, Suzanne Nielsen, Gabrielle Campbell, et al.
Drug and Alcohol Review|July 31, 2015
Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, AustraliaSuzanne Nielsen, Raimondo Bruno, Bridin Murnion, et al.
Drug and Alcohol Review|February 4, 2025
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open-label, non-randomised trial of long-acting injectable buprenorphine treatment in Australian custodial settingsBethany White, Sophia Little, Paul S Haber, et al.
Pageof 20